Malignant tumors under immunosuppression, new problem in transplant recipients
Enderlin, F.; Guisan, Y.
Schweizerische Rundschau für Medizin Praxis 62(34): 1031-1035
1973
ISSN/ISBN: 1013-2058 PMID: 4582307 Document Number: 62271
Document emailed within 1 workday
Related Documents
Vilardell, J.; Oppenheimer, F.; Talbot-Wright, R.; Ricart, M.J.; Andreu, J.; Alcaraz, A.; Carretero, P. 1992: Increased risk of malignant tumors in renal transplant recipients receiving cyclosporine Transplantation Proceedings 24(5): 1948Agha, I.A.; Rueda, J.; Alvarez, A.; Singer, G.G.; Miller, B.W.; Flavin, K.; Lowell, J.A.; Shenoy, S.; Howard, T.K.; Ramachandran, V.; Irish, W.; Schnitzle, M.A.; Brennan, D.C. 2002: Short course induction immunosuppression with thymoglobulin for renal transplant recipients Transplantation 73(3): 473-475
Nawaz, S.Haider.; Zafar, M.Naqi.; Naqvi, S.Ali.Anwar.; Rizvi, S.Adibul.Hasan. 2005: Impact of cyclosporin immunosuppression on serum magnesium and its fractional excretion in renal transplant recipients Jpma. Journal of the Pakistan Medical Association 55(3): 98-100
Gajarski, R.J.; Smith, E.O.; Denfield, S.W.; Rosenblatt, H.M.; Kearney, D.; Frazier, O.H.; Radovancevic, B.; Price, J.K.; Kertesz, N.J.; Towbin, J.A. 1998: Long-term results of triple-drug-based immunosuppression in nonneonatal pediatric heart transplant recipients Transplantation 65(11): 1470-1476
Laufer, G.; Miholic, J.; Laczkovics, A.; Wollenek, G.; Holzinger, C.; Hajek-Rosenmeier, A.; Wuzl, G.; Schreiner, W.; Buxbaum, P.; Wolner, E. 1989: Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression Journal of Thoracic and Cardiovascular Surgery 98(6): 1113-1121
Salomon, D.R. 1991: An alternative view minimizing the significance of cyclosporine nephrotoxicity and in favor of enhanced immunosuppression for long-term kidney transplant recipients Transplantation Proceedings 23(4): 2115-2118
Durando, C. 1984: Current possibilities of the timely diagnosis, preoperative staging and prevention of malignant tumors of the ovary. A) Diagnostic problem of malignant ovarian tumors Minerva Ginecologica 36(4): 143-144
Sivathasan, C.; Doraisingham, S.; Ling, A.E.; Ng, A.; Allen, D.M.; Tong, M.C. 1992: Is cytomegalovirus infection going to be a problem among heart transplant recipients in Singapore? Transplantation Proceedings 24(5): 2019-2021
Euvrard, S.; Kanitakis, J.; Claudy, A. 2002: Cutaneous tumors in organ transplant recipients Presse Medicale 31(40): 1895-1903
Cassidy, M.J.; Disler, P.B.; Swanepoel, C.R.; Jacobson, J.E.; Pontin, A.R. 1982: De novo malignant tumours in renal transplant recipients South African Medical Journal 62(2): 58-60
Blagojević-Lazić, R.; Radivojević, D.; Andrejević, V.; Dzamić, Z.; Acimović, M.; Milutinović, D.; Djurasić, L.; Hadzi-Djokić, J. 2012: Malignant disease in renal transplant recipients--our experience Acta Chirurgica Iugoslavica 59(1): 49-51
Wojtyś, M.łg.; Janowski, H.; Wójcik, J.; Kubisa, B.; Pieróg, J.ła.; Grodzki, T. 2012: Surgical treatment of malignant lung tumors in solid organ recipients Pneumonologia i Alergologia Polska 80(4): 343-348
Yagisawa, T. 1988: Clinical and pathological studies of cyclosporin-treated kidney transplant recipients. First report: Study of recipients with long-term graft function Nihon Jinzo Gakkai Shi 30(7): 865-873
Kumar, D.; Fattah, H.; Kimball, P.M.; LeCorchick, S.; McDougan, F.A.; King, A.L.; Gupta, G. 2016: Post-transplant Desensitization for Deceased Donor Kidney Transplant Recipients: a Single Center Experience Clinical Transplants 32: 143-151
Mirza, S.; Mahmud, S.N.; Abideen, Z.U.; Aziz, T.; Akhter, S.; Baloch, B.K. 2019: Overcoming the Immunological Barrier in Highly HLA Sensitized Renal Transplant Recipients - a Desensitization Experience from a Transplant Center in Pakistan JPMA. Journal of the Pakistan Medical Association 69(4): 584-587
Kimball, P.M.; King, A. 2011: A novel post-transplant alloantibody surveillance and intervention strategy that improves graft outcomes in sensitized renal transplant recipients Clinical Transplants 2011: 369-372
Lim, T.T.; Botas, J.; Ross, H.; Liang, D.H.; Theodore, J.; Hunt, S.A.; Oesterle, S.N.; Yeung, A.C. 1996: Are heart-lung transplant recipients protected from developing transplant coronary artery disease? A case-matched intracoronary ultrasound study Circulation 94(7): 1573-1577
Mann, W. 1985: Problem of the surgical treatment of malignant tumors of the hypopharynx and cervical esophagus Hno 33(8): 359-363
Mohr, H.J. 1971: Multiple malignant primary tumors. a depressing human and an alarming medical problem Minerva Ginecologica 23(2): 91-101
Grant, D.; Rochon, J.; Levy, G. 1996: Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group Transplantation Proceedings 28(4): 2232-2233